The United Kingdom has expanded its research visa programme to include a fast-track Global Talent Visa pathway for more than 100 companies, including pharmaceutical giant AstraZeneca and automaker Jaguar Land Rover (JLR), according to a report cited by CNBC-TV18.

The initiative is designed to attract highly skilled workers to the UK by streamlining the visa process for eligible companies. Under the expanded programme, qualifying organisations can sponsor talented researchers and professionals more efficiently, reducing bureaucratic delays that have traditionally slowed recruitment of international talent. The Global Talent Visa, which replaced the earlier Tier 1 Exceptional Talent route in 2020, also allows holders to work flexibly without being tied to a single employer and offers a path to permanent settlement, making it one of the UK's most attractive immigration routes for senior researchers and innovators.

AstraZeneca, headquartered in Cambridge, is one of the world's largest pharmaceutical companies and a major employer of scientific research talent across the UK. The company has been deepening its domestic R&D footprint, including its flagship Discovery Centre in Cambridge, which opened in 2021 and houses over 2,000 scientists. Jaguar Land Rover, a British automotive manufacturer and subsidiary of India's Tata Motors, likewise relies on specialised engineering and technology professionals to support its vehicle development and electrification efforts under its Reimagine strategy, which targets a fully electric Range Rover by 2025 and all-electric options across all models by 2030. Both companies operate in sectors the UK government has identified as strategic priorities for economic growth.

The UK government's move comes amid a broader tightening of immigration policies in the United States, including sustained restrictions on certain work visa categories that have created friction for employers seeking international talent. This has opened a window for other countries to position themselves as destinations for skilled workers. By accelerating visa approvals for high-demand sectors such as life sciences and advanced manufacturing, the UK aims to strengthen its competitive position in the global race for talent.

The expansion of the Global Talent Visa programme reflects ongoing UK efforts to bolster research and innovation capacity following its departure from the European Union, a transition that ended freedom of movement and raised concerns about potential labour shortages in science, technology, and engineering fields. The UK's life sciences sector alone supports over 280,000 jobs nationally, and the government has set out a Life Sciences Vision to grow the industry's contribution to the economy, making access to international expertise a critical enabling factor.

Source: CNBC-TV18